|
|
||||||||
Clinical Chemistry, Vol 35, 256-259, Copyright © 1989 by American Association for Clinical Chemistry
S Tas
Department of Pathology, Kuwait University Faculty of Medicine, Safat.
A potential genetic marker for hypertriglyceridemia and coronary disease, an apolipoprotein-CIII gene allele displaying a single nucleotide substitution, was found in 71% of Arabs with primary hypertriglyceridemia. Over 96% of the unrelated adults possessing this allele showed hypertriglyceridemia. The same allele was found rarely among normotriglyceridemic subjects. In further support of involvement in hypertriglyceridemia, this allele was co-inherited with increased serum triglycerides in a three-generation family. Moreover, a gene dosage effect was also found. A mechanism of action for the allele is suggested by the findings that the subjects possessing the allele show markedly increased very-low-density lipoproteins, decreased high- density lipoproteins, and borderline chylomicronemia demonstrable by lipoprotein electrophoresis. Electrophoresis of the selectively amplified-restricted apolipoprotein-CIII DNA on agarose gel provides a rapid diagnostic test that allows identification of the subjects with this allele in less than a day.
The following articles in journals at HighWire Press have cited this article:
![]() |
Q.-f. Wang, X. Liu, J. O'Connell, Z. Peng, R. M. Krauss, D. L. Rainwater, J. L. VandeBerg, Edward. M. Rubin, J.-F. Cheng, and L. A. Pennacchio Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons Hum. Mol. Genet., May 15, 2004; 13(10): 1049 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Pennacchio, M. Olivier, J. A. Hubacek, R. M. Krauss, E. M. Rubin, and J. C. Cohen Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels Hum. Mol. Genet., November 15, 2002; 11(24): 3031 - 3038. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Dallinga-Thie, M. Groenendijk, R. N. H. H. C. Blom, T. W. A. De Bruin, and E. De Kant Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin J. Lipid Res., September 1, 2001; 42(9): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reddy, W. Yang, D. G. Taylor, X.-q. Shen, D. Oxender, G. Kust, and T. Leff Mitogen-activated Protein Kinase Regulates Transcription of the ApoCIII Gene. INVOLVEMENT OF THE ORPHAN NUCLEAR RECEPTOR HNF4 J. Biol. Chem., November 12, 1999; 274(46): 33050 - 33056. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Groenendijk, R. M. Cantor, N. H. H. C. Blom, J. I. Rotter, T. W. A. de Bruin, and G. M. Dallinga-Thie Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia J. Lipid Res., June 1, 1999; 40(6): 1036 - 1044. [Abstract] [Full Text] |
||||
![]() |
M. C. Jong, M. H. Hofker, and L. M. Havekes Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3 Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 472 - 484. [Full Text] [PDF] |
||||
![]() |
E. M. Wijsman, J. D. Brunzell, G. P. Jarvik, M. A. Austin, A. G. Motulsky, and S. S. Deeb Evidence Against Linkage of Familial Combined Hyperlipidemia to the Apolipoprotein AI-CIII-AIV Gene Complex Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 215 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Hegele, P. W. Connelly, A. J. G. Hanley, F. Sun, S. B. Harris, and B. Zinman Common Genomic Variation in the APOC3 Promoter Associated With Variation in Plasma Lipoproteins Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2753 - 2758. [Abstract] [Full Text] |
||||
![]() |
R. A. Hegele, P. W. Connelly, A. J.G. Hanley, F. Sun, S. B. Harris, and B. Zinman Common Genomic Variants Associated With Variation in Plasma Lipoproteins in Young Aboriginal Canadians Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1060 - 1066. [Abstract] [Full Text] |
||||
![]() |
A. P. Surguchov, G. P. Page, L. Smith, W. Patsch, and E. Boerwinkle Polymorphic Markers in Apolipoprotein C-III Gene Flanking Regions and Hypertriglyceridemia Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 941 - 947. [Abstract] [Full Text] |
||||
![]() |
R. A. Hegele, J. H. Brunt, and P. W. Connelly Genetic Variation on Chromosome 1 Associated With Variation in Body Fat Distribution in Men Circulation, September 1, 1995; 92(5): 1089 - 1093. [Abstract] [Full Text] |
||||
![]() |
R. A. Hegele, J. H. Brunt, and P. W. Connelly Multiple Genetic Determinants of Variation of Plasma Lipoproteins in Alberta Hutterites Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 861 - 871. [Abstract] [Full Text] |
||||
![]() |
Y Ito, N Azrolan, A O'Connell, A Walsh, and J. Breslow Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice Science, August 17, 1990; 249(4970): 790 - 793. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |